MPI
GILD icon

Mairs & Power Inc’s Gilead Sciences GILD Stock Holding History

Mairs & Power Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Hold
2,275
– – ﹤0.01% 212
2025
Q4 		$279K Hold
2,275
– – ﹤0.01% 215
2025
Q3 		$253K Sell
2,275
-226
-9% -$25.7K ﹤0.01% 222
2025
Q2 		$277K Buy
+2,501
New +$266K ﹤0.01% 205

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mairs & Power Inc's GILD Position: Q1 2026 in Review

Mairs & Power Inc held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,275 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #212.

Mairs & Power Inc first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mairs & Power Inc held 2,275 shares of Gilead Sciences worth $317K as of Q1 2026.
  • Mairs & Power Inc left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Mairs & Power Inc's portfolio in Q1 2026, its #212 holding.
  • Mairs & Power Inc first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mairs & Power Inc's 13F filing for Q1 2026, filed 14 May 2026.